Pilot study of combination therapy with ribavirin and interferon alfa por the retreatment of chronic hepatitis B e antibody-positive patients.
Cotonat T, Quiroga JA, López-Alcorocho JM, Clouet R, Pardo M, Manzarbeitia F,Carreño V. Hepatology 2000; 31: 502-506